Indegene bolsters life sciences marketing business with CultHealth buyout aliu Fri, 10/21/2022 – 15:48 More: Indegene bolsters life sciences marketing business with CultHealth buyout Source: fierce
read moreRegeneron’s Eylea scores coveted pediatric exclusivity, extending its market hold by 6 months zbecker Fri, 10/21/2022 – 11:17 More: Regeneron's Eylea scores coveted pediatric exclusivity, extending its market hold by 6 months Source: fierce
read moreAbbVie’s Allergan teams with women advocacy group in call for ‘Breaking Barriers in STEM’ aliu Fri, 10/21/2022 – 11:10 More: AbbVie's Allergan teams with women advocacy group in call for 'Breaking Barriers in STEM' Source: fierce
read moreGSK’s HIV franchise could reach £7B in 2026, analyst says, as real-world data start backing long-acting Cabenuva aliu Fri, 10/21/2022 – 10:35 More: GSK's HIV franchise could reach £7B in 2026, analyst says, as real-world data start backing long-acting Cabenuva
read morePfizer eyes four-fold price hike for COVID vaccine in private US market kdunleavy Fri, 10/21/2022 – 10:31 More: Pfizer eyes four-fold price hike for COVID vaccine in private US market Source: fierce
read moreResearchers assessed whether measuring DNA shed by cancer cells into the bloodstream could track tumour progression More: ICR’s new study tracks disease progression in children with rare type of cancer Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals